Intelligence · Clinical Pipeline
Theravance Biopharma Ireland Pipeline
All ClinicalTrials.gov programs at Theravance Biopharma Ireland — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
Theravance Biopharma Ireland has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Revefenacin
Theravance Biopharma Ireland Umited
Chronic Obstructive Pulmonary Disease, COPD
2 trials -
TD-1473 Dose A
Theravance Biopharma Ireland Umited
Ulcerative Colitis (UC)
2 trials -
TD-4208
Theravance Biopharma Ireland Umited
Chronic Obstructive Pulmonary Disease (COPD)
4 trials -
ampreloxetine
Theravance Biopharma Ireland Umited
Symptomatic Neurogenic Orthostatic Hypotension
4 trials
Frequently asked questions
How many pipeline programs does Theravance Biopharma Ireland have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs